|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-8-14
|
|
pubmed:abstractText |
Approximately one-third of patients with osteosarcoma who have a complete response to their initial treatment can be expected to relapse. It is important to define what host, tumor, or treatment characteristics determine outcome after relapse. We present findings in 59 patients treated at our institution from 1974 to 1996 who have relapsed one or more times after their initial response.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1545-5009
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
255-9
|
|
pubmed:dateRevised |
2009-1-12
|
|
pubmed:meshHeading |
pubmed-meshheading:16123980-Adolescent,
pubmed-meshheading:16123980-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16123980-Cohort Studies,
pubmed-meshheading:16123980-Female,
pubmed-meshheading:16123980-Follow-Up Studies,
pubmed-meshheading:16123980-Humans,
pubmed-meshheading:16123980-Male,
pubmed-meshheading:16123980-Neoplasm Recurrence, Local,
pubmed-meshheading:16123980-Osteosarcoma,
pubmed-meshheading:16123980-Questionnaires,
pubmed-meshheading:16123980-Recurrence,
pubmed-meshheading:16123980-Retrospective Studies,
pubmed-meshheading:16123980-Risk Factors,
pubmed-meshheading:16123980-Survival Rate,
pubmed-meshheading:16123980-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
|
|
pubmed:affiliation |
Department of Pediatrics, UCSF Children's Hospital, San Francisco, California 94143-0106, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
